Limits...
The role of somatostatin in 67 consecutive pancreatectomies: a randomized clinical trial.

Katsourakis A, Oikonomou L, Chatzitheoklitos E, Noussios G, Pitiakoudis M, Polychronidis A, Simopoulos K, Sioga A - Clin Exp Gastroenterol (2010)

Bottom Line: Biopsies were taken and processed for electron microscopy and ultrastructural morphometric analysis.Administration of somatostatin reduced the exocrine granule number, and the patients suffered from fewer postoperative complications.Somatostatin reduces granule number and size of pancreatic cells, which can partially explain the prophylactic effect of the drug on early complications of pancreatic surgery, and which is confirmed by the clinical findings.

View Article: PubMed Central - PubMed

Affiliation: Surgical Department of "Agios Dimitrios" General Hospital, Thessaloniki, Greece;

ABSTRACT

Background: Somatostatin has been found to be effective in the prevention of postoperative complications in pancreatic surgery. It can inhibit the pancreatic secretions that, quite often, are responsible for complications during the postoperative period.

Methods: We randomized 67 patients in 2 groups. In the study group (n = 35), somatostatin was administered 30 minutes prior to surgery as well as intraoperatively and postoperatively. No medication was given to the control group (n = 32). Biopsies were taken and processed for electron microscopy and ultrastructural morphometric analysis.

Results: Administration of somatostatin reduced the exocrine granule number, and the patients suffered from fewer postoperative complications.

Conclusions: Somatostatin reduces granule number and size of pancreatic cells, which can partially explain the prophylactic effect of the drug on early complications of pancreatic surgery, and which is confirmed by the clinical findings.

No MeSH data available.


Related in: MedlinePlus

Control patient. Acinar cells with very dilated rough endoplasmic reticulum (rer).Abbreviation: N, nucleus × 8000.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3108665&req=5

f1-ceg-3-179: Control patient. Acinar cells with very dilated rough endoplasmic reticulum (rer).Abbreviation: N, nucleus × 8000.

Mentions: In control patients the acini were normal with many membrane-bound granules of variable size, dilated rough endoplasmic reticulum, and many Golgi complexes (Figures 1 and 2).


The role of somatostatin in 67 consecutive pancreatectomies: a randomized clinical trial.

Katsourakis A, Oikonomou L, Chatzitheoklitos E, Noussios G, Pitiakoudis M, Polychronidis A, Simopoulos K, Sioga A - Clin Exp Gastroenterol (2010)

Control patient. Acinar cells with very dilated rough endoplasmic reticulum (rer).Abbreviation: N, nucleus × 8000.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3108665&req=5

f1-ceg-3-179: Control patient. Acinar cells with very dilated rough endoplasmic reticulum (rer).Abbreviation: N, nucleus × 8000.
Mentions: In control patients the acini were normal with many membrane-bound granules of variable size, dilated rough endoplasmic reticulum, and many Golgi complexes (Figures 1 and 2).

Bottom Line: Biopsies were taken and processed for electron microscopy and ultrastructural morphometric analysis.Administration of somatostatin reduced the exocrine granule number, and the patients suffered from fewer postoperative complications.Somatostatin reduces granule number and size of pancreatic cells, which can partially explain the prophylactic effect of the drug on early complications of pancreatic surgery, and which is confirmed by the clinical findings.

View Article: PubMed Central - PubMed

Affiliation: Surgical Department of "Agios Dimitrios" General Hospital, Thessaloniki, Greece;

ABSTRACT

Background: Somatostatin has been found to be effective in the prevention of postoperative complications in pancreatic surgery. It can inhibit the pancreatic secretions that, quite often, are responsible for complications during the postoperative period.

Methods: We randomized 67 patients in 2 groups. In the study group (n = 35), somatostatin was administered 30 minutes prior to surgery as well as intraoperatively and postoperatively. No medication was given to the control group (n = 32). Biopsies were taken and processed for electron microscopy and ultrastructural morphometric analysis.

Results: Administration of somatostatin reduced the exocrine granule number, and the patients suffered from fewer postoperative complications.

Conclusions: Somatostatin reduces granule number and size of pancreatic cells, which can partially explain the prophylactic effect of the drug on early complications of pancreatic surgery, and which is confirmed by the clinical findings.

No MeSH data available.


Related in: MedlinePlus